Sakar Healthcare Limited
NSE: SAKAR · Other · sector
₹970.80NSE close 2026-10-26
Key numbers
Market cap₹2,160 cr
Price₹970.80
52w high / low₹1,230 / ₹352
P/E59.9xSector median 14.4x
P/B6.7xSector median 1.7x
Book value₹145.8
Dividend yield–Sector median 0.37%
ROE11.8%Sector median 13.8%
ROCE14.8%Sector median 19.6%
OPM28.5%Sector median 10.4%
Debt / equity0.17xSector median 0.29x
EV/EBITDA28.0xSector median 8.4x
Interest cover7.6x
Current ratio1.28x
Sales growth 3y+23.6%Sector median +7.7%
Profit growth 3y+33.7%Sector median +16.6%
PEG2.17x
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 688 companies in Other (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹50 cr vs borrowings ₹55 cr (FY26): borrowings are higher by ₹5 cr.
- Operating profit covered interest 7.6x in the last 12 months.
- Promoter holding fell by 1.16 percentage points in a year, to 51.70% (2026-09-30).
- Operating cash flow was below net profit in 0 of the last 5 years.
- Revenue was higher than a year earlier in 4 of the last 4 quarters.
- Other income was 10% of net profit in the last 12 months.
- Debtor days went from 50 (FY24) to 0 (FY26).
- No dividend in the last 5 financial years.
- Price ₹970.80 on 2026-10-26: -21.1% from the 52-week high, +175.8% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹1,152.35 · low ₹227.69
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 43 | 43 | 50 | 53 | 58 | 70 | 71 | 73 |
| EBITDA | 12 | 12 | 16 | 13 | 11 | 19 | 26 | 21 |
| OPM % | 26.9% | 27.0% | 31.3% | 24.1% | 19.7% | 26.4% | 36.9% | 29.1% |
| Other income | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 2 |
| Net profit | 5 | 5 | 6 | 5 | 5 | 10 | 11 | 10 |
| EPS (₹) | 2.17 | 2.08 | 2.66 | 2.11 | 2.03 | 4.59 | 4.96 | 4.62 |
| Revenue YoY | +34.5% | +62.0% | +41.5% | +38.4% | ||||
| Profit YoY | -5.4% | +126.3% | +91.3% | +120.1% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 128 | 133 | 153 | 178 | 252 | 272 |
| EBITDA | 29 | 33 | 38 | 50 | 69 | 77 |
| Net profit | 15 | 13 | 12 | 18 | 30 | 36 |
| EPS (₹) | 8.73 | 6.59 | 5.64 | 7.97 | 13.70 | 16.20 |
| Revenue growth | +4.0% | +15.0% | +15.8% | +41.8% | +43.8% | |
| Profit growth | -14.6% | -8.5% | +50.0% | +74.2% | +82.7% | |
| Dividend / share (₹) | – | – | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +23.6% | +21.6% | +43.8% |
| Net profit | +33.7% | +23.3% | +82.7% |
| EPS | +27.6% | +14.8% | – |
| Share price | – | +68.8% (2y) | +148.0% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 173 | 262 | 285 | 324 |
| Borrowings | – | 111 | 69 | 75 | 55 |
| Cash & equivalents | – | 4 | 0 | 0 | 50 |
| Total assets | – | 336 | 389 | 415 | 481 |
| Fixed assets | – | 267 | 313 | 304 | 319 |
| Capital work in progress | – | 6 | 0 | 17 | 4 |
| Investments | – | 0 | 0 | 0 | 0 |
| Receivables | – | 22 | 21 | 31 | 0 |
| Inventory | – | 15 | 28 | 44 | 70 |
| Payables | – | 26 | 27 | 21 | 52 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 36 | 33 | 24 | 36 | 49 |
| Cash from investing | -90 | -74 | -52 | -32 | -28 |
| Cash from financing | 55 | 41 | 27 | -3 | -21 |
| Capex | 98 | 82 | 60 | 32 | 0 |
| Free cash flow | -62 | -49 | -35 | 3 | 49 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | 7.4% | 4.4% | 6.1% | 9.4% |
| ROCE % | – | 8.0% | 7.1% | 8.3% | 12.5% |
| Debtor days | – | 60 | 50 | 63 | 0 |
| Inventory days | – | 76 | 121 | 193 | 207 |
| Payable days | – | 129 | 120 | 93 | 153 |
| Cash conversion cycle (days) | – | 7 | 51 | 163 | 54 |
| Working capital days | – | 4 | 30 | 52 | 45 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 51.70% |
| FIIs | 12.34% |
| DIIs | 11.92% |
| Public (non-institutions) | 24.04% |
| Quarter | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 53.58% | 53.58% | 52.86% | 52.86% | 52.86% | 52.86% | 52.52% | 51.70% |
| Promoter group | % |
|---|---|
| Sanjay S Shah | 44.98% |
| Shah Aarsh | 5.60% |
| Ritaben Shah | 1.10% |
| Shah Ayushi | 0.02% |
| Public holders above 1% | % |
|---|---|
| Tata Capital Healthcare Fund II | 10.38% |
| Hbm Healthcare Investments (Cayman) Ltd | 6.74% |
| Cobra India (Mauritius) Limited | 3.49% |
19,539 shareholders. Pledged: – of promoter shares.
Peers in Other
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| TSFINV | ₹8,585 cr | 17.6x | 1.4x | 8.4% | 3.6% | 20.5% | +121.7% | 2.30% |
| KRISHANA | ₹6,339 cr | 39.9x | 11.3x | 41.6% | 23.2% | 12.6% | +95.7% | 0.05% |
| MARINE | ₹5,431 cr | 84.2x | 11.0x | 14.3% | 18.0% | 10.8% | +25.6% | 0.07% |
| ZOTA | ₹4,139 cr | – | 6.0x | -22.5% | -12.4% | -0.5% | +56.7% | 0.07% |
| AIMTRON | ₹3,319 cr | 71.7x | 17.1x | 28.0% | 31.8% | 21.8% | – | – |
| ACCORD | ₹2,984 cr | – | 261.7x | 12.4% | 12.0% | 2.4% | – | – |
| MONOLITH | ₹2,646 cr | 64.6x | 24.3x | 36.0% | 48.7% | 24.4% | – | – |
| UTSSAV | ₹2,390 cr | 40.2x | 14.1x | 43.4% | 54.7% | 7.9% | – | – |
| BETA | ₹2,200 cr | 40.6x | 5.0x | 16.4% | 17.0% | 20.8% | – | – |
| SAKAR | ₹2,160 cr | 59.9x | 6.7x | 11.8% | 14.8% | 28.5% | +23.6% | – |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2024-09-13 | Other | Annual General Meeting |
| 2023-09-14 | Other | Annual General Meeting |
| 2022-09-12 | Other | Annual General Meeting |
| 2021-09-16 | Other | Annual General Meeting |
| 2020-09-16 | Other | Annual General Meeting |
| 2019-09-06 | Other | Annual General Meeting |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Annual report FY22
- Announcements NSE filings
- Latest results (data file) XBRL
Links go to the original files on the exchange website.
About the company
| Sector | |
| Industry | Other |
| Sub-industry | |
| Symbol | SAKAR |
| BSE code | – |
| ISIN | INE732S01012 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-22 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.